28 May 2024 - The Korean Research based Pharma Industry Association (KRPIA) called for the 22nd National Assembly, which is set to open on Thursday, to "improve treatment environment to patient-oriented one and create a pharmaceutical ecosystem that reflects the innovative value of new drugs that extend people's healthy life spans" in Korea that has entered into an ultra low birthrate and a superaged society.

Noting that both the ruling and opposition parties have pledged to actively support the development of the pharmaceutical and biotechnology industry and enhance access to treatment for patients with serious and rare diseases through their general election pledges, KRPIA also called for legal and institutional support for the nation to grow into a true healthcare powerhouse.

Read Korea Biomedical Review article